Last month (November 2019), we came across a promising report (see below) of a new drug designation created by the FDA: the “Regenerative Medicine Advanced Therapy” (RMAT). This designation was actually announced back in early 2017, but we suspect many readers may not know about it yet, so we’d like to share it here!